Bal Pharma Ltd. logo

Bal Pharma Ltd. (BALPHARMA)

Market Open
7 Aug, 10:00
XNSE XNSE
89. 23
+2.34
+2.6931%
2.1B Market Cap
- P/E Ratio
4.8% Div Yield
14,255 Volume
- Eps
86.89
Previous Close
Add Transaction
Day Range
86.97 89.59
Year Range
60 98.85
Want to track BALPHARMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Bal Pharma Ltd. (BALPHARMA) Statistics

Valuation metrics

Market Cap 2.1B
Enterprise value 2.94B
Trailing P/E (ttm) 22.53
Forward P/E -
PEG ratio -1.21
Price/Sales (ttm) 0.46
Price/Book (mrq) 1.73
Enterprise Value/Revenue 0.94
Enterprise Value/EBITDA 8.79

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 14.95K
Average volume (90 days) 45.23K

Price summary

52-Week low 60
52-Week high 98.85
Beta -
50-Day moving average 84.9
200-Day moving average 78.41

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.2
Trailing annual dividend yield 0.0134%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 10 Oct 2025
Ex-Dividend Date 18 Sep 2025
Last split factor -
Last split Date -

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.02%
Operating margin 0.07%

Operational effectiveness

Return on assets 0.02%
Return on equity 0.08%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 196.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.95
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 5.84
Total debt (mrq) -
Total Debt/Equity (mrq) 1.94
Current ratio (mrq) 1.05%
Book value per share (mrq) 51.73

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -